KRAS and adenoma: In this group, 58 polyps were analyzed (41 tubular adenomas with low-grade dysplasia, 15 HP and 2 sessile serrated adenoma/polyps (SSA/p) and 13.8% were KRAS-mutated (n = 8/58) while 20.7% were BRAF-mutated (n = 12/58) (Table 3).